141 – 150 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival.
(
- Contribution to journal › Article
-
Mark
Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.
(
- Contribution to journal › Article
-
Mark
Purine analogues: rationale for development, mechanisms of action, and pharmacokinetics in hairy cell leukemia.
(
- Contribution to journal › Article
- 2005
-
Mark
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
(
- Contribution to journal › Article
-
Mark
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
(
- Contribution to journal › Article
-
Mark
Monitoring oral cyclosporine therapy
(
- Contribution to journal › Letter
-
Mark
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Insamling av navelsträngsblod bör finansieras offentligt
(
- Contribution to journal › Letter
- 2004
-
Mark
Identification of a commonly amplified 4.3 Mb region with overexpression of the C8FW gene, encoding a phosphoprotein regulated by mitogenic pathways, but not of the MYC gene in MYC-containing double minutes in myeloid malignancies.
(
- Contribution to journal › Article
- 2003
-
Mark
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study
(
- Contribution to journal › Article